Acasti Pharma Inc. (ACST) SEC Filing 20-F Annual report for the fiscal year ending Saturday, March 31, 2018

Document And Entity Information

Note 20 - Financial Instruments

Statements Of Cash Flows (twelve Month And Month Ended 2017 Unaudited)

Statements Of Changes In Equity (twelve Month And Month Ended 2017 Unaudited)

Statements Of Changes In Equity (twelve Month And Month Ended 2017 Unaudited) (parentheticals)

Statements Of Earnings And Comprehensive Loss (twelve Month And Month Ended 2017 Unaudited)

Statements Of Financial Position (february 2017 Unaudited)

Note 1 - Reporting Entity

Note 1 - Reporting Entity (details Textual)

Note 10 - Trade And Other Payables

Note 10 - Trade And Other Payables (tables)

Note 10 - Trade And Other Payables - Components Of Trade And Other Payables (details)

Note 11 - Derivative Warrant Liabilities

Note 11 - Derivative Warrant Liabilities (details Textual)

Note 11 - Derivative Warrant Liabilities (tables)

Note 11 - Derivative Warrant Liabilities - Assumptions (details)

Note 11 - Derivative Warrant Liabilities - Reconciliation (details)

Note 12 - Unsecured Convertible Debentures

Note 12 - Unsecured Convertible Debentures (details Textual)

Note 12 - Unsecured Convertible Debentures (tables)

Note 12 - Unsecured Convertible Debentures - Liability And Equity Component Portions (details)

Note 13 - Capital And Other Components Of Equity

Note 13 - Capital And Other Components Of Equity (details Textual)

Note 13 - Capital And Other Components Of Equity (tables)

Note 13 - Capital And Other Components Of Equity - Assumptions (details)

Note 13 - Capital And Other Components Of Equity - Unsecured Convertible Debentures (details)

Note 13 - Capital And Other Components Of Equity - Warrants Outstanding (details)

Note 14 - Personnel Expenses

Note 14 - Personnel Expenses (tables)

Note 14 - Personnel Expenses - Components Of Personnel Expenses (details)

Note 15 - Financial Expenses

Note 15 - Financial Expenses (tables)

Note 15 - Financial Expenses - Components Of Finance Income (expenses) (details)

Note 16 - Share-based Payments

Note 16 - Share-based Payments (details Textual)

Note 16 - Share-based Payments (tables)

Note 16 - Share-based Payments - Option Activity (details)

Note 16 - Share-based Payments - Outstanding And Exercisable Options (details)

Note 16 - Share-based Payments - Weighted Average Assumptions (details)

Note 17 - Loss Per Share

Note 18 - Supplemental Cash Flow Disclosure

Note 18 - Supplemental Cash Flow Disclosure (tables)

Note 18 - Supplemental Cash Flow Disclosure - Changes In Non-cash Operating Items (details)

Note 18 - Supplemental Cash Flow Disclosure - Non-cash Transactions (details)

Note 19 - Income Taxes

Note 19 - Income Taxes (details Textual)

Note 19 - Income Taxes (tables)

Note 19 - Income Taxes - Deferred Tax (recovery) Expense (details)

Note 19 - Income Taxes - Reconciliation Of Effective Tax Rate (details)

Note 19 - Income Taxes - Tax Attributes And Temporary Differences Available To Reduce Future Years' Taxable Income (details)

Note 19 - Income Taxes - Unrecognized Deferred Tax Assets (details)

Note 2 - Basis Of Preparation

Note 2 - Basis Of Preparation (details Textual)

Note 20 - Financial Instruments (tables)

Note 20 - Financial Instruments - Currency Risk (details)

Note 20 - Financial Instruments - Financial Liabilities (details)

Note 20 - Financial Instruments - Interest Rate Risk (details)

Note 21 - Commitments And Contingencies

Note 21 - Commitments And Contingencies (details Textual)

Note 22 - Determination Of Fair Values

Note 22 - Determination Of Fair Values (details Textual)

Note 23 - Capital Management

Note 23 - Capital Management (details Textual)

Note 23 - Capital Management (tables)

Note 23 - Capital Management - Cash And Cash Equivalents (details)

Note 24 - Subsequent Event

Note 24 - Subsequent Event (details Textual)

Note 3 - Significant Accounting Policies

Note 3 - Significant Accounting Policies (details Textual)

Note 3 - Significant Accounting Policies (tables)

Note 3 - Significant Accounting Policies - Estimated Useful Lives And Rates (details)

Note 4 - Receivables

Note 4 - Receivables (tables)

Note 4 - Receivables - Schedule Of Receivables (details)

Note 5 - Other Assets

Note 5 - Other Assets (details Textual)

Note 6 - Related Parties

Note 6 - Related Parties (details Textual)

Note 6 - Related Parties (tables)

Note 6 - Related Parties - Administrative And Research And Development Expenses (details)

Note 6 - Related Parties - Key Management Personnel Compensation (details)

Note 7 - Government Assistance

Note 7 - Government Assistance (tables)

Note 7 - Government Assistance - Government Grants And Investment Tax Credits (details)

Note 7 - Government Assistance - Unrecognized Federal Tax Credits (details)

Note 8 - Equipment

Note 8 - Equipment (details Textual)

Note 8 - Equipment (tables)

Note 8 - Equipment - Components Of Equipment (details)

Note 9 - Intangible Assets

Note 9 - Intangible Assets (tables)

Note 9 - Intangible Assets - Components Of Intangible Assets (details)

Significant Accounting Policies (policies)